治療方案

Viartril®-S維固力™

結晶型硫酸鹽葡萄糖胺 – 骨科醫生推薦No.1 藥物*

紓緩關節痛1–3

Viartril®-S維固力™（通用名稱：結晶型硫酸鹽葡萄糖胺crystalline glucosamine sulphate）1-2由意大利一所大學the University of Pavia的教授Prof Luigi Rovati與他的同僚研發製造4，能靈活關節5、紓緩痛楚3、延緩退化6和修復軟骨6 。

為何選擇Viartril®-S維固力™

維固力™在香港衛生署註冊，擁有40年歷史，紓緩關節疼痛的療效不但遠比傳統止痛藥（撲熱息痛）較佳，亦可改善關節活動功能5,7。

由於結晶型葡萄糖胺的配方較為穩定，更易被人體吸收 + 8-9，維固力™是骨科醫生推薦No.1品牌*。

*根據kantar Hong Kong於2019對40位註冊私家骨科醫生的訪問結果
+與鹽酸鹽葡萄糖胺相比

更多產品資訊…

國際指引建議

Viartril®-S維固力™（crystalline glucosamine sulphate）為歐洲醫學權威ESCEO（European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases）推薦的一線藥物之一5,10 。

  • 參考資料PM-VIS-24-042302 May 2024

    1. Viartril®-S Capsules 250 mg & 500mg Package Insert. Version L1086D.
    2. Viartril®-S Sachets 1500mg Package Insert. Version L1019F.
    3. Eriksen P, et al. Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials. Arthritis Care Res (Hoboken). 2014;66(12):1844-1855.
    4. Patterson A. The development and validation of a near infrared application for the qualitative identification of Plantago ovata husk granules. NIR news. 2013;24(1):8-10.
    5. Buyere O, et al. Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016;45(4 Suppl):S12-S17.
    6. Sun Y, et al. Repairing effects of glucosamine sulfate in combination with etoricoxib on articular cartilages of patients with knee osteoarthritis. J Orthop Surg Res. 2020;15(1):150.
    7. Viartril®-S capsules 314 mg registration. Hong Kong Department of Health. 2024. Available at: https://www.drugoffice.gov.hk/eps/drug/productDetail/en/pharmaceutical_trade/144042#. Accessed on April 23, 2024.
    8. Persiani S, et al. Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man. Oesteoarth. Cartilage. 2005; 13: 1041-1049.
    9. Kucharz E, et al. A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other glucosamines to maximize clinical outcomes. Curr Med Res Opin. 2016; 32(6): 997-1004.
    10. Buyere O, et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting. Semin Arthritis Rheum. 2016;45(4 Suppl):S3-S11.

相關疾病

痛症

了解更多 ...